Advertisement
U.S. markets close in 1 hour 44 minutes
  • S&P 500

    5,253.56
    +5.07 (+0.10%)
     
  • Dow 30

    39,788.15
    +28.07 (+0.07%)
     
  • Nasdaq

    16,381.79
    -17.73 (-0.11%)
     
  • Russell 2000

    2,124.02
    +9.67 (+0.46%)
     
  • Crude Oil

    83.02
    +1.67 (+2.05%)
     
  • Gold

    2,242.60
    +29.90 (+1.35%)
     
  • Silver

    25.00
    +0.25 (+1.02%)
     
  • EUR/USD

    1.0797
    -0.0033 (-0.30%)
     
  • 10-Yr Bond

    4.2020
    +0.0060 (+0.14%)
     
  • GBP/USD

    1.2623
    -0.0015 (-0.12%)
     
  • USD/JPY

    151.3990
    +0.1530 (+0.10%)
     
  • Bitcoin USD

    70,921.81
    +2,347.55 (+3.42%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • FTSE 100

    7,952.62
    +20.64 (+0.26%)
     
  • Nikkei 225

    40,168.07
    -594.66 (-1.46%)
     

Can the Rally in Keryx Biopharmaceuticals (KERX) Shares Continue?

Keryx Biopharmaceuticals (KERX) been on the move lately as the stock has risen by 5.96% in the past four weeks, and it is currently trading well above its 20-Day SMA. This is a pretty solid move higher, but the question that has to be on investors’ minds right now is; can this trend continue?

While there can be no telling for sure, it is certainly encouraging that earnings estimates have risen in the past few weeks on the company, suggesting that sentiment on KERX is moving in the right direction. In fact, the stock currently has a Zacks Rank #2 (Buy), suggesting that the recent run could certainly continue for this in-focus company.




KERYX BIOPHARMACEUTICALS INC (KERX): Free Stock Analysis Report


Zacks Investment Research

Advertisement